ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,996.66
1.00%
US Tech 100
20,877.20
1.72%
다우존스 지수
43,487.83
0.78%
Bitcoin
102,596.12
-1.47%
Registration Strip Icon for charts 실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. USOTC

  6. Elite Pharmaceuticals Inc (QB) (ELTP) 시세

Elite Pharmaceuticals Inc (QB)

Elite Pharmaceuticals Inc (QB) (ELTP)

USOTC
0.49265
0.00065
(0.13%)
마감 18 1월 6:00AM
15분 지연

실시간 스트리밍 인용문, 아이디어 및 실시간 토론을 위한 허브

프리미엄

주요 통계 및 세부정보

가격
0.49265
매수가
0.4903
매도가
0.4989
거래량
821,834
0.48144 일간 변동폭 0.4989
0.1213 52주 범위 0.7598
market_cap
526.285M
전일 종가
0.492
개장가
0.49
최근 거래 시간
100
@
0.49265
마지막 거래 시간
재정 규모
US$ 401,610
VWAP
0.488675
평균 볼륨(3m)
1,923,445
발행 주식
1,068,273,108
배당수익률
-
주가수익률
26.06
주당순이익(EPS)
0.02
매출
56.63M
순이익
20.11M

Elite Pharmaceuticals Inc (QB) 정보

Elite Pharmaceuticals, Inc. is a specialty pharmaceutical company that develops niche generic products. Elite specializes in developing and manufacturing oral, controlled-release drug products. Elite owns multiple generic products which have been licensed to Lannett Company, Prasco, LLC, Epic Pharma... Elite Pharmaceuticals, Inc. is a specialty pharmaceutical company that develops niche generic products. Elite specializes in developing and manufacturing oral, controlled-release drug products. Elite owns multiple generic products which have been licensed to Lannett Company, Prasco, LLC, Epic Pharma, LLC, and TAGI Pharma. Elite operates a cGMP and DEA registered facility for research, development, and manufacturing located in Northvale, NJ. For more information, visit www.elitepharma.com. 더 보기

섹터
Pharmaceutical Preparations
산업
Pharmaceutical Preparations
웹사이트
www.elitepharma.com
본부
Carson City, Nevada, USA
설립됨
-
Elite Pharmaceuticals Inc (QB) is listed in the Pharmaceutical Preparations sector of the OTC 시장 with ticker ELTP. The last closing price for Elite Pharmaceuticals (QB) was US$0.49. Over the last year, Elite Pharmaceuticals (QB) shares have traded in a share price range of US$ 0.1213 to US$ 0.7598.

Elite Pharmaceuticals (QB) currently has 1,068,273,108 shares in issue. The market capitalisation of Elite Pharmaceuticals (QB) is US$525.59 million. Elite Pharmaceuticals (QB) has a price to earnings ratio (PE ratio) of 26.06.

ELTP 최신 뉴스

추가 뉴스

Form 8-K - Current report

27 12월 2024
Edgar (US Regulatory)

Form 8-K - Current report

03 12월 2024
Edgar (US Regulatory)

Form 8-K - Current report

19 11월 2024
Edgar (US Regulatory)

Form 8-K - Current report

15 11월 2024
Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

15 11월 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

29 10월 2024
Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities

23 10월 2024
Edgar (US Regulatory)

ZenaTech, Inc. (NASDAQ: ZENA) Software Company Acquisition

ZenaTech, Inc. (NASDAQ: ZENA) Software Company Acquisition     Miami, FL – October 23, 2024 -- InvestorsHub NewsWire – EmergingGrowth.com, a leading...

23 10월 2024
InvestorsHub NewsWire

Form 8-K - Current report

11 10월 2024
Edgar (US Regulatory)

Form 8-K - Current report

28 8월 2024
Edgar (US Regulatory)
기간변동변동 %시가고가저가평균 일일 거래량VWAP
10.002650.5408163265310.490.51440.472110470240.4939129CS
4-0.07735-13.57017543860.570.57990.4513242810.52319814CS
12-0.08735-15.06034482760.580.720.432119234450.54793432CS
260.30115157.258485640.19150.75980.162623766720.46022734CS
520.30765166.2972972970.1850.75980.121316610030.37922306CS
1560.44765994.7777777780.0450.75980.02689819530.24801229CS
2600.39215390.1990049750.10050.75980.0239744930.17339716CS

ELTP - Frequently Asked Questions (FAQ)

What is the current Elite Pharmaceuticals (QB) share price?
The current share price of Elite Pharmaceuticals (QB) is US$ 0.49265
How many Elite Pharmaceuticals (QB) shares are in issue?
Elite Pharmaceuticals (QB) has 1,068,273,108 shares in issue
What is the market cap of Elite Pharmaceuticals (QB)?
The market capitalisation of Elite Pharmaceuticals (QB) is USD 525.59M
What is the 1 year trading range for Elite Pharmaceuticals (QB) share price?
Elite Pharmaceuticals (QB) has traded in the range of US$ 0.1213 to US$ 0.7598 during the past year
What is the PE ratio of Elite Pharmaceuticals (QB)?
The price to earnings ratio of Elite Pharmaceuticals (QB) is 26.06
What is the cash to sales ratio of Elite Pharmaceuticals (QB)?
The cash to sales ratio of Elite Pharmaceuticals (QB) is 9.25
What is the reporting currency for Elite Pharmaceuticals (QB)?
Elite Pharmaceuticals (QB) reports financial results in USD
What is the latest annual turnover for Elite Pharmaceuticals (QB)?
The latest annual turnover of Elite Pharmaceuticals (QB) is USD 56.63M
What is the latest annual profit for Elite Pharmaceuticals (QB)?
The latest annual profit of Elite Pharmaceuticals (QB) is USD 20.11M
What is the registered address of Elite Pharmaceuticals (QB)?
The registered address for Elite Pharmaceuticals (QB) is 321 W. WINNIE LANE, #104, CARSON CITY, NEVADA, 89703
What is the Elite Pharmaceuticals (QB) website address?
The website address for Elite Pharmaceuticals (QB) is www.elitepharma.com
Which industry sector does Elite Pharmaceuticals (QB) operate in?
Elite Pharmaceuticals (QB) operates in the PHARMACEUTICAL PREPARATIONS sector

이동자

모두 보기
  • 가장 활성
  • % 상승자
  • % 패자
기호가격볼륨
TMGIMarquie Group Inc (PK)
US$ 0.0002
(19,900.00%)
4.03M
SEANSAEAN Group Inc (PK)
US$ 1.87
(18,600.00%)
100
BRGOBergio International Inc (PK)
US$ 0.0001
(9,900.00%)
540k
GMPRGourmet Provisions International Corporation (PK)
US$ 0.0001
(9,900.00%)
35.31M
PLPLPlandai Biotechnology Inc (PK)
US$ 0.0001
(9,900.00%)
18.06M
STNXStartronix International Inc (CE)
US$ 0.000001
(-99.99%)
450
AWINAERWINS Technologies Inc (CE)
US$ 0.000001
(-99.97%)
2.03k
ISOLImage Software Inc (CE)
US$ 0.000001
(-99.91%)
59.2k
NBIONascent Biotech Inc (CE)
US$ 0.0002
(-99.55%)
8.7k
FHBCFernhill Beverage Inc (CE)
US$ 0.000001
(-99.24%)
10k
GTCHGBT Technologies Inc (PK)
US$ 0.0001
(0.00%)
349.77M
VTXBVortex Brands Company (PK)
US$ 0.0002
(0.00%)
297.52M
EMEDElectroMedical Technologies Inc (PK)
US$ 0.0002
(0.00%)
233.53M
PHILPHI Group Inc (PK)
US$ 0.0002
(-33.33%)
184.12M
HMBLHUMBL Inc (PK)
US$ 0.0009
(-5.26%)
179.2M

ELTP Discussion

게시물 보기
NASDAQ2020 NASDAQ2020 6 시간 전
N2Ks DCF formulae to determine co. value.
http://moneychimp.com/articles/valuation/dcf.htm
👍️0
mrwrn2010 mrwrn2010 10 시간 전
Same way we've seen updated statuses of the legal cases without PRs to date - go look.
👍️ 1 💦 1
IB_ IB_ 10 시간 전
Almost makes one wonder why there are those here who will defend EVER questionable move the CEO makes ..............

What are they trying to condition us for ????????????????

I hope I'm wrong, but I suspect some major self-serving BS coming,

IB_🤴
🙄 1 🥱 1
NASDAQ2020 NASDAQ2020 11 시간 전
https://www.pacermonitor.com/public/case/51356241/PURDUE_PHARMA_LP_et_al_v_ELITE_LABORATORIES_INC,_et_al
👍️ 1
IB_ IB_ 11 시간 전
Something bigger than MLK is happening Monday, right ???????????

IB_🤴
😆 1 🤪 1
luvwetscent luvwetscent 11 시간 전
Someone finally calling S for what is was...and yet some on the board still worship His Highness
👍️ 1
jour_trader jour_trader 11 시간 전
I check it every morning. Can't wait. 
👍️ 1
JamesF1 JamesF1 11 시간 전
I am looking forward to Elite being on this FDA list as available https://www.accessdata.fda.gov/scripts/drugshortages/dsp_ActiveIngredientDetails.cfm?AI=Lisdexamfetamine%20Dimesylate%20Capsule&st=c
👍️0
Maxthedog Maxthedog 11 시간 전
There been so many days going down as they (don't know who they are) decided around 2-1/2 months ago to gradually bring the price down at a snail's pace. Watching the paint dry but with a touch of downside.
The biggest positive news in ELTP entire lifespan was generic Vyvanse being approved and launched and we're no longer a one trick pony. And Takeda is losing huge amounts of money to the generic version of Vyvanse. We are definitely not late to the party Adding the new facility was perfect timing.
👍️ 1
JamesF1 JamesF1 12 시간 전
MLK Jr day Monday. No trading.
👍️ 2
snupoled snupoled 12 시간 전
Sounds like a plan!
snup
👍️0
snupoled snupoled 12 시간 전
very very unusual, the shares I bought today
are slightly green, first time in two months
Maybe we hit bottem?
Make it a great weekend!
snup
😂 1
BuddyGuise BuddyGuise 12 시간 전
$ELTP Thinking this will be the last week of "in the 40's" for us. Slowest volume week for months tells me that longs are soaking shares (cause that’s what I’ve been doing the past two weeks) and those that want out with a profit have done so. Anticipation of another tremendous quarterly report in February will bring in more volume, imo. I know we’ve all heard it before, but I believe that this will be the last week of cheap shares. Hope you topped off the tanks and are ready to run!

👍️ 7 💰️ 1 🙏 1 🚀 1
snupoled snupoled 13 시간 전
Whoooops, 643 k a hair over 49 cents,
man elite can break ones heart
make it a great weekend
snup
👍️0
IB_ IB_ 14 시간 전
When a company is profitable & growing, I would never assume a buyout is their only option ......

To uplist and hopefully bring in institutional investors is a win win for all shareholders, with possibly the exception of ONE !!!!!!!!

All matters that are legal are not always honest .............

As a shareholder of Elite, I would be interested in knowing what price SunGen asked us to pay for their Adderall ...... Elite, unlike Mikah, is NOT a private company,

IB_🤴
👍️ 1 🤕 1 🤢 1
HGilS HGilS 14 시간 전
Nasrat always wanted to List to Nasdaq but I do not know if you heard, the stock was kept down under 5 cents for years - artificially - so it made it very hard for him to do so.

It is true that he said when we get to 15-25 cents levels we will go to Nasdaq - but when you align 6 new drugs in 8 months, and you move to needle movers, the best strategy is to focus on growth and Profit.

It is not yet the time to buy back stock - each $ will bring more friends if invested wisely in R&D,

We will see an listing to NASDAQ in due time - organically.
👍️ 2
jour_trader jour_trader 15 시간 전
You can use uplisting path as leverage to a buyer and make it seem like a buyout is not the only option. I could see some buyers cornering CEO in negotiations. As more time passes, we get more leverage, rev grows, profits grow and we expand internationally and clean up our outstanding shares. It could be a great long term play, but just don't think that's what Nasrat has in mind. 
👍️ 1
jangofett jangofett 15 시간 전
To the people that complain about the price action GTFOH. 🐂🤑🤑🤑🤑🤑
👍️ 2 💯 4
IB_ IB_ 16 시간 전
I agree,

"Elite has never had an IR dept that actually acts in that capacity. For some reason, CEO wants to keep Elite as quiet as possible. I'm not sure he wants us to actually uplist. I'd prefer this, but don't think he wants additional scrutiny and accountability. Once active investors get involved they are relentless. I think Nasrat wants to avoid this. He likely doesn't care where the share price is today"

Wonder why he has spoken numerus times about uplisting to the Nasdaq over the past 12 years ??????????

Why would he talk about it if he did not want it to happen ???????????

Hummm,

IB_🤴
🤐 1 🤣 2 🥸 1
sharkey1 sharkey1 16 시간 전
Over on the OTC there is about 300k on the ask at .50, let's see if the market makers let it run
👍️0
IB_ IB_ 16 시간 전
Well, I see The nasrat worshippers and The Pom Pom crew did not like this post, Snup !!!!!!!!!!!!!!

The TRUTH will get you attacked these days, Snup,

IB_🤴
🗑️ 4 🥱 3
snupoled snupoled 16 시간 전
do the exact opposite! and youll be fine!
I think I will regret coming back to elite

snup
❓️ 3
NASDAQ2020 NASDAQ2020 16 시간 전
Let us know when you buy so we can get ready, lol
👍️0
jour_trader jour_trader 16 시간 전
Elite has never had an IR dept that actually acts in that capacity. For some reason, CEO wants to keep Elite as quiet as possible. I'm not sure he wants us to actually uplist. I'd prefer this, but don't think he wants additional scrutiny and accountability. Once active investors get involved they are relentless. I think Nasrat wants to avoid this.  He likely doesn't care where the share price is today because we have no need for additional liquidity. I think he is prioritizing a sale of the company so he can immediately liquidate and this will happen all in due time.
👍️ 1
HGilS HGilS 16 시간 전
what is really frustrating is that you blame everyone for leaving the boat and coming back on it after seeing it did not drown and now the ticket price went up...
👍️ 1
rocioyogi rocioyogi 16 시간 전
Oh…….. ON Ignore!
👍️ 2
rocioyogi rocioyogi 16 시간 전
Simple solution : sell and go back into hibernation
👍️ 5
snupoled snupoled 17 시간 전
Very Frustrating, I have bought a few more
and Down She Goes!

Can't believe how many shareholders holding for past 5 years
are content with a non-existent ir dept.

One sentence on monster revenue producer Vyvase and we are okay with that?
we are a growth stock but say nothing about revenue dynamics for 2025-2026
we have a ceo implying 50 cents is great, yet we know our goal for years
is nasdaq and taking out the dollar?
we are profitable on the otc market, who knows this?
am I having buyers remorse, and only been here two months?
snup
👍️ 1
HGilS HGilS 17 시간 전
we have more volume than yesterday by 10 am
👍️0
JamesF1 JamesF1 17 시간 전
Thanks for the response barttrab1, all the best to you and your son.
👍️ 1
jdd21 jdd21 17 시간 전
Snup for better or worse Nasrat will not self promote the stock.  He let's the results speak for itself.  Maybe not as good for the stock price in the short run but in the long run the price will take care of itself and all of us that have shares will be very happy.
🎓️ 2 👍️ 4 💯 2 💲 1
barttrab11 barttrab11 17 시간 전
No, my son takes them sporadically since he only needs them on heavy school or homework days and college just started back up this week.
👍️ 2
JamesF1 JamesF1 17 시간 전
The brand name company loses a large percent of market share as soon as a generic comes to market. A second generic coming to market doesn’t affect the brand name company much. My GUESS is Purdue will try to negotiate a payment from Elite to settle the suit. If Elite does not agree, Purdue continues the litigation for a few more months, then probably loses. Elite has to decide if getting their generic to market quicker is worth the price. This is just speculation on my part.
👍️ 2
rack186 rack186 17 시간 전
Given your record of fantasy prediction, and being the lead choreographer for "team pump", a resounding NOPE, I say, to that "could go down in history"
Sorry, this is what happens when you over hype
every aspect of this stock. IE; Vyvanse flop..!!
🗑️ 2 🧻 2
IB_ IB_ 17 시간 전
👸, The very few short shares that you see will be covered with the shares at the next desk !!!!!!!

There are "0" short shares from retail investors ...............

The Market Makers see all !!!!!!!!

Continue on, our little board 🤡,

IB_🤴
👍️0
HGilS HGilS 17 시간 전
Puzzling...
Purdue took Accord through courts again and again, they went to several levels of courts, a very long process and expensive too.

See how they handle Elite.... 6 Months stay...
Conference call to discuss the next steps.... mmmmmm

Why the different approach??????

----------------------
If I'm reading it correctly, they can settle this thing over the phone. Both parties agreed to comply with the Accord verdict.
and it should go in Elites favor for (obvious) reasons.
my next guess
The Judge sends a CC copy to each party concerned then a CC to the FDA, then the FDA guys send it to their lawyers They
have to sign off, then they send it back to the FDA guys, then the FDA sends the approval to Elite, then Elite can start making
generic Oxycontin,,
simple as that
badda bing badda boom
👍️ 1
NASDAQ2020 NASDAQ2020 17 시간 전
Forget 5 months. Jan 22 could go down in the history books.

OxyContin will raise the BuyOut Price EVEN MORE !!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
👍️ 2 💰️ 1 🥵 1
NASDAQ2020 NASDAQ2020 17 시간 전
Does Accord use different ADF tech on their generic OxyContin ???
👍️0
NASDAQ2020 NASDAQ2020 17 시간 전
Shorts are puckering up for the good news.

$720 Million market
👍️0
NASDAQ2020 NASDAQ2020 17 시간 전
Shorts sweating it out or may cover before Verdict.

Its About To Get Real !!!!!!!!!!!!!!!!!!!!!

ELTP
👍️ 4
snupoled snupoled 17 시간 전
Is Vyvanase going to be a monster revenue producer or not?
Is elite a growth stock?
Is taking out a buck on our agenda?

hell yeah new money, new interest , new investors need to know!
I know elite will wake up and act like they are a publically traded company, and soon!

snup
👍️0
namtae namtae 17 시간 전
Snup, Sequest was a scam perpetrated on investors which tainted the company for years. Unfortunate you got caught up in it and was forced to sell missing the recent run up
👍️0
snupoled snupoled 18 시간 전
JD, and there it is, HOW? this will take new eyes/fresh interest/money
longs that are holding for years is not new money

I am back because I have been here before, new launches will bring in
monster revs, I know this from following the company not from non existent Ir
What does ir Dianne do all day?

I did not re enter stock from single sentance on vyvanase launch.

We are a growth stock and elite has got to change with the times.

loyal longs waiting for many years say they are to busy to self promote elite
the balance sheet and cc will suffice, this is why manipulators are here between
each cc. elite being silent totally predictable

snup

snup
💤 1
JamesF1 JamesF1 18 시간 전
Barttrab11, have you filled a generic Vyvanse rx yet? Please let us know when you do.
👍️0
snupoled snupoled 18 시간 전
Namtae,
I'm one of those people who held
into the sequestox decision, half my
position, great loss that year

snup
👍️ 1
sharkey1 sharkey1 18 시간 전
WOW, they are making deals again, in the pharma industry

https://finance.yahoo.com/news/mega-m-jp-morgan-conference-123806846.html
👍️ 4 💯 1 💰️ 1 💲 2 💵 1
jdd21 jdd21 18 시간 전
It would be nice to get back to .60 before it starts to go up on earnings.
👍️ 1
JamesF1 JamesF1 18 시간 전
Thanks for the post Sharkey1, it looks like the Oxycontin litigation is close to being settled. I am optimistic, but it’s not over till it’s over 🍀
👍️ 5
rack186 rack186 19 시간 전
Team pump in overdrive.... you'll have 5 months
to spew that fantasy, then what ??
You are shameless, good Lord.
🗑️ 2 🧻 2
jammy32 jammy32 19 시간 전
How would we know. Nasrat doesn’t have a PR process.
👍️0

최근 히스토리

USOTC
ELTP
Elite Pharmaceuticals (QB)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

대한민국
회사 소개
사업
Popular
앱 받기
App Store
Google Play

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2025 ADVFN PLC - 모든 권리 보유